The Cigna Group (CI) is down 5.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver is a sector-wide selloff after federal regulators proposed a broad anti-fraud rule that tightens oversight of Medicare Advantage and Part D plans, which pressured health insurers across the group. This could be because investors are reassessing regulatory and repayment risk for managed-care companies, even though Cigna has less direct Medicare Advantage exposure than some peers after prior portfolio changes. ([cms.gov](https://www.cms.gov/newsroom/fact-sheets/comprehensive-regulations-uncover-suspicious-healthcare-crush-proposed-rule-cms-6098-p))
Details:
Sources:
Centers for Medicare & Medicaid Services, The Cigna Group, SEC
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CI Insider Trading Activity
$CI insiders have traded $CI stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:
- NICOLE S JONES (See Remarks) has made 0 purchases and 2 sales selling 22,113 shares for an estimated $6,118,099.
- JAMIE G KATES (Chief Accounting Officer) sold 899 shares for an estimated $268,452
- EVERETT NEVILLE (See Remarks) sold 617 shares for an estimated $175,258
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CI Hedge Fund Activity
We have seen 711 institutional investors add shares of $CI stock to their portfolio, and 898 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 106,265,806 shares (-99.6%) from their portfolio in Q3 2026, for an estimated $28,886,234,044
- GQG PARTNERS LLC removed 5,887,858 shares (-99.6%) from their portfolio in Q3 2026, for an estimated $1,600,496,440
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 2,178,861 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $592,279,785
- FMR LLC removed 1,205,174 shares (-15.0%) from their portfolio in Q3 2026, for an estimated $327,602,448
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,083,937 shares (-87.8%) from their portfolio in Q3 2026, for an estimated $294,646,594
- NATIONAL BANK OF CANADA /FI/ removed 855,895 shares (-59.6%) from their portfolio in Q3 2026, for an estimated $232,657,937
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 839,488 shares (+41.5%) to their portfolio in Q3 2026, for an estimated $228,198,023
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CI Government Contracts
We have seen $3,232,020 of award payments to $CI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MEDICAL, DENTAL, AND VISION INSURANCE FOR THE MNG STUDENTS AND DEPENDENTS IN CONUS SCHOOLS/TRAINING.: $3,217,401
- VEHICLE INSURANCE: $14,619
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$CI Analyst Ratings
Wall Street analysts have issued reports on $CI in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/19/2026
- Piper Sandler issued a "Overweight" rating on 11/12/2026
- Bernstein issued a "Outperform" rating on 11/11/2026
- Guggenheim issued a "Buy" rating on 11/06/2026
- Cantor Fitzgerald issued a "Overweight" rating on 11/06/2026
- Raymond James issued a "Outperform" rating on 08/03/2026
To track analyst ratings and price targets for $CI, check out Quiver Quantitative's $CI forecast page.
$CI Price Targets
Multiple analysts have issued price targets for $CI recently. We have seen 11 analysts offer price targets for $CI in the last 6 months, with a median target of $340.0.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $346.0 on 11/19/2026
- Stephen Baxter from Wells Fargo set a target price of $325.0 on 11/13/2026
- David Windley from Jefferies set a target price of $304.0 on 11/12/2026
- Jessica Tassan from Piper Sandler set a target price of $360.0 on 11/12/2026
- Lance Wilkes from Bernstein set a target price of $390.0 on 11/11/2026
- Andrew Mok from Barclays set a target price of $320.0 on 11/09/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $320.0 on 11/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.